Oncology & Cancer

Immune cells in lung cancer offer new drug targets

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College have found.

Oncology & Cancer

Study points to potential new lung cancer therapy

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

Oncology & Cancer

Researchers identify genes responsible for lung tumors

The lung transcription factor Nkx2-1 is an important gene regulating lung formation and normal respiratory functions after birth. Alterations in the expression of this transcription factor can lead to diseases such as lung ...

Oncology & Cancer

Lung cancer risk model refines decisions to screen

A new method for determining lung cancer risk could more efficiently identify individuals for annual screening and catch more cancers early, according to a study published in this week's PLOS Medicine. The study, conducted ...

Oncology & Cancer

Tumor-associated neutrophils boost anti-tumor immune responses

Lung cancer is a leading cause of cancer-related deaths in both men and women, and survival depends on the stage of cancer at diagnosis. An inflammatory response is induced following tumor formation, and the immune cells ...

page 16 from 21